Ambroxol Sustained Release 75 mg [Design Issues]

posted by MaggieSantos – Portugal, 2016-10-28 20:16 (2728 d 15:58 ago) – Posting: # 16755
Views: 3,377

Dear colleagues,

I have been asked to perform a bioequivalence study on ambroxol, sustained release formulations containing 75 mg. according to guideline a single dose fast study as well as a single dose fed may be applicable. The multiple dose study is also required due to accumulation, according to ambroxol half-life between 7 and 12 hours.

I would like to have inputs from experienced researchers in order to aware of any concerns related to this substance.

Kind Regards

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,662 registered users;
65 visitors (0 registered, 65 guests [including 2 identified bots]).
Forum time: 12:15 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5